Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000545
Filing Date
2025-03-31
Accepted
2025-03-31 07:30:26
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bcli-20241231x10k.htm   iXBRL 10-K 2632357
2 EX-10.83 bcli-20241231xex10d83.htm EX-10.83 66007
3 EX-19.1 bcli-20241231xex19d1.htm EX-19.1 42276
4 EX-21 bcli-20241231xex21.htm EX-21 6248
5 EX-23.1 bcli-20241231xex23d1.htm EX-23.1 2600
6 EX-31.1 bcli-20241231xex31d1.htm EX-31.1 9648
7 EX-31.2 bcli-20241231xex31d2.htm EX-31.2 10299
8 EX-32.1 bcli-20241231xex32d1.htm EX-32.1 5908
9 EX-32.2 bcli-20241231xex32d2.htm EX-32.2 5925
10 GRAPHIC bcli-20241231x10k001.jpg GRAPHIC 5624
11 GRAPHIC bcli-20241231xex10d83001.jpg GRAPHIC 5003
  Complete submission text file 0001410578-25-000545.txt   7841520

Data Files

Seq Description Document Type Size
12 EX-101.SCH bcli-20241231.xsd EX-101.SCH 42303
13 EX-101.CAL bcli-20241231_cal.xml EX-101.CAL 34182
14 EX-101.DEF bcli-20241231_def.xml EX-101.DEF 163567
15 EX-101.LAB bcli-20241231_lab.xml EX-101.LAB 340678
16 EX-101.PRE bcli-20241231_pre.xml EX-101.PRE 293265
82 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20241231x10k_htm.xml XML 1051204
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36641 | Film No.: 25788918
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)